HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO) has ...
With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...
The sham device looked identical to the active one and delivered electrical pulses for 30 seconds at the start of every hour. This intermittent pulsing mimicked the physical sensation of the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results